A Phase I Investigation of MK-5108 and MK-5108 With Docetaxel in Patients with Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2008
At a glance
- Drugs MK 5108 (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 30 Oct 2008 Updated from The Cancer Institute of New Jersey site.
- 04 Aug 2008 New trial record.